FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes

Mise à jour : Il y a 4 ans
Référence : NCT00743925

Femme et Homme

Extrait

The objective of this study is to evaluate the safety and efficacy of A 002 when added to high dose atorvastatin in subjects with an acute coronary syndrome (ACS)


Critère d'inclusion

  • Acute coronary syndrome

Liens